Neutralizing Antibodies to SARS-CoV-2
A high-throughput test that can predict neutralizing activities is a critical step toward understanding herd immunity to covid-19.
Read MorePosted by Laurie Bonner | Jan 15, 2021 | Uncategorized |
A high-throughput test that can predict neutralizing activities is a critical step toward understanding herd immunity to covid-19.
Read MorePosted by Melanie Hamilton-Basich | Jan 13, 2021 | Covid 19 |
The BARDA funding is for the validation and submission of the Simplexa Covid-19 Direct kit and the Simplexa Covid-19 & Flu A/B Direct kit for FDA 510(k) clearance.
Read MorePosted by Melanie Hamilton-Basich | Jan 13, 2021 | Covid 19, Lab Automation |
Aim Lab covid-19 PathFinder benchtop automation solutions can help overcome many covid-19-related challenges.
Read MorePosted by Melanie Hamilton-Basich | Jan 13, 2021 | Covid 19 |
Ortho Clinical Diagnostics’ Vitros SARS-CoV-2 Antigen Test has become the first high-volume covid-19 antigen test to receive FDA emergency use authorization.
Read MorePosted by Melanie Hamilton-Basich | Jan 12, 2021 | Covid 19, Flu & Respiratory Infections, POC Rapid Assays |
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read More